97
Yin H#, Wang S# , Qu J , Zhou F , Wang C* , Cao B* , For CAP-China. Long-term prognosis of adolescent and middle-aged Chinese patients with low-medium risk community-acquired pneumonia: a cohort study. Clin Respir J. 2020 May 31. doi: 10.1111/crj.13224.
98
Zhang Y#, Wang Y, Zhao J, Xiong Z, Fan Y, Zhang W, Zou X, Wang C, Han J, Li B, Lu B, Cao B*, CAP-China Network. Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China. Influenza Other Respir Viruses. 2020 May 25.doi: 10.1111/irv.12754.
99
Gu X#, Zhou F, Wang Y, Fan G, Cao B*. Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment. Eur Respir Rev. 2020 Jul 21;29(157):200038. doi: 10.1183/16000617.0038-2020. Print 2020 Sep 30.
100
Sun L#, Chen W#, Li H# , Li L#, Zou X , Zhao J, Lu B , Li B, Wang C , Li H , Liu Y, Cao B*. Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background. J Antimicrob Chemother. 2020 Jul 28;dkaa241. doi: 10.1093/jac/dkaa241.
101
Xu J#, Huang C#, Fan G#, Liu Z#, Shang L, Zhou F, Wang Y, Yu J, Yang L, Xie K, Huang Z, Huang L, Gu X, Li H, Zhang Y, Wang Y, Hayden F G, Horby P W, Cao B*, Wang C*. Use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front. Med., [online ahead of print] doi: 10.1007/s11684-020-0800-y
102
Jiuyang Xu#, Jiapei Yu, Luning Yang, Fei Zhou, Hui Li, Bin Cao*. Influenza Virus in Community-Acquired Pneumonia: Current Understanding and Knowledge Gaps. Semin Respir Crit Care Med 2020;00:1–13.DOI:https://doi.org/10.1055/s-0040-1710584.
103
Jiuyang Xu#,Jiapei Yu,Luning Yang,Fei Zhou,Hui Li,Bin Cao*.Influenza Virus in Community-Acquired Pneumonia:Current Understanding and Knowledge Gaps.Semin Respir Crit Care Med 2020;00:1–13.DOI:https://doi.org/10.1055/s-0040-1710584.
104
Yeming Wang#, Dingyu Zhang#, Guanhua Du#, Ronghui Du#, Jianping Zhao#, Yang Jin#, Shouzhi Fu#, Ling Gao#, Zhenshun Cheng#, Qiaofa Lu#,Yi Hu#, Guangwei Luo#,Bin Cao*, Chen Wang*.Remdesivir in adults with severe COVID-19: a randomised,double-blind, placebo-controlled, multicentre trial.The Lancet,Published Online April 29, 2020,DOI:https://doi.org/10.1016/S0140-6736(20)31022-9
105
Hui Li#, Liang Liu#, Dingyu Zhang#, Jiuyang Xu, Huaping Dai, Nan Tang, Xiao Su, Bin Cao*.SARS-CoV-2 and viral sepsis: observations and hypotheses.The Lancet,Published Online,April 17, 2020,DOI:https://doi.org/10.1016/S0140-6736(20)30920-X
106
Jiankang Zhao#,Chao Liu,Yingmei Liu,Yulin Zhang,Zhujia Xiong,Yanyan Fan,Xiaohui Zou,Binghuai Lu,Bin Cao*. Genomic characteristics of clinical important ST11 Klebsiella pneumoniaeworldwide. Journal of Global Antimicrobial Resistance, Available online 8 April 2020.DOI: https://doi.org/10.1016/j.jgar.2020.03.023.
107
Chen W#, Sun L#, Guo L, Cao B, Liu Y, Zhao L, Lu B, Li B, Chen J*, Wang C*. Clinical outcomes of ceftazidime-avibactam in lung transplant recipients with infections caused by extensively drug-resistant gram-negative bacilli. Ann Transl Med. 2020 Feb;8(3):39. doi: 10.21037/atm.2019.10.40.
108
Cao B#*, Wang Y#, Wen D#, Liu W#, Wang J#, Fan G#, Ruan L#, Song B#, Cai Y#, Wei M#, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D*, Wang C*.A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med. 2020 Mar 18.
109
Fei Zhou#, Ting Yu#, Ronghui Du#, Guohui Fan#, Ying Liu#, Zhibo Liu#, Jie Xiang#, Hua Chen*, Bin Cao*.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet 2020 Published online March 9, 2020,DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
110
Xiao jing Cui#,Lei Gao#,Bin Cao*.Management of Latent Tuberculosis Infection in China: Exploring solutions suitable for high-burden countries.International Journal of Infectious Diseases,Available online 27 February 2020.DOI:https://doi.org/10.1016/j.ijid.2
111
Zhang Y, Xu J, Li H, Cao B, A novel coronavirus (COVID-19) outbreak: a call for action, CHEST (2020), doi: https://doi.org/10.1016/j.chest.2020.02.014.
112
Gu XY#, Cao B*, Wang JW. Full spectrum of 2019-nCoV disease severity still being depicted. Lancet 2020 February 14,DOI:https://doi.org/10.1016/S0140-6736(20)30371-8
